Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Infection”

1,916 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,916 results

Early research (Phase 1)Study completedNCT03961438
What this trial is testing

Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine

Who this might be right for
HIV-1-infection
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24
Testing effectiveness (Phase 2)Study completedNCT00251537
What this trial is testing

A Pilot Study of LTB4 in HIV-1 Infected Adults

Who this might be right for
HIV Infections
LTB4 Sweden AB 40
Early research (Phase 1)Study completedNCT00393276
What this trial is testing

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)Ended earlyNCT02355184
What this trial is testing

An Extension of Protocol PRO 140_CD01 Study

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 20
Large-scale testing (Phase 3)Study completedNCT02403674
What this trial is testing

Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)

Who this might be right for
Human Immunodeficiency Virus (HIV)
Merck Sharp & Dohme LLC 734
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Large-scale testing (Phase 3)Study completedNCT05306704
What this trial is testing

High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial

Who this might be right for
HIV-1-infectionHypovitaminosis D
University of the Punjab 95
Early research (Phase 1)Study completedNCT00001043
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT01966822
What this trial is testing

Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density

Who this might be right for
HIV-1 Infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 75
Early research (Phase 1)UnknownNCT00013572
What this trial is testing

HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
Walter Reed Army Institute of Research (WRAIR) 36
Testing effectiveness (Phase 2)Study completedNCT00352911
What this trial is testing

Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects

Who this might be right for
HIV Infections
VGX Pharmaceuticals, LLC 19
Not applicableLooking for participantsNCT06492187
What this trial is testing

Triage Survey for Infectious Disease Eligibility

Who this might be right for
Vaccination; InfectionHIV-1-infectionInfectious Disease
Brooklyn Clinical Research 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT05300035
What this trial is testing

Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control

Who this might be right for
HIV/AIDS and Infections
ANRS, Emerging Infectious Diseases 69
Large-scale testing (Phase 3)Active Not RecruitingNCT06544733
What this trial is testing

Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

Who this might be right for
HIV-1-Infection
Gilead Sciences 675
Large-scale testing (Phase 3)Study completedNCT02227238
What this trial is testing

Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment

Who this might be right for
HIV Infections
ViiV Healthcare 627
Not applicableLooking for participantsNCT06127290
What this trial is testing

HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia

Who this might be right for
HIV-1-infection
Euresist Network GEIE 200
Testing effectiveness (Phase 2)Study completedNCT00642291
What this trial is testing

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

Who this might be right for
HIV Infections
Gilead Sciences 16
Not applicableStudy completedNCT02461576
What this trial is testing

Clinical Evaluation of the Xpert® HIV-1 VL

Who this might be right for
Human Immunodeficiency Virus
Cepheid 966
Large-scale testing (Phase 3)Active Not RecruitingNCT04150068
What this trial is testing

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance

Who this might be right for
HIV-1-infection
Gilead Sciences 72
Testing effectiveness (Phase 2)Study completedNCT00413725
What this trial is testing

Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 801
Load More Results